One of the principle problems when dealing with prostate cancer is that 30–50 % of patients who receive curative therapy for presumed local disease confined to the prostate will develop a rising PSA indicative of recurrence. The differentiation of local prostatic recurrence from more widespread disease will determine whether the patient is a candidate for a local salvage procedure or whether he is best served by a systemic approach or combinations thereof. …